How unfair is the coin?

Lessons on Building an AI x Bio Startup

How unfair is the coin? Ankit Gupta Blog Contact / Github / How unfair is the coin? Monday. January 06, 2025 I’m reviving my blog after some time away — it’s been an eventful 12 months. In February 2024, Reverie Labs, the startup I co-founded in 2017, was acquired by Ginkgo Bioworks. I’m now on leave from Ginkgo and I’ve joined Y Combinator as a Visiting Partner, giving me the chance to work with the next generation of companies. Especially in this new role, I’ve been thinking a bit about what worked, what didn’t work, and what lessons I can take forward. We had quite the journey – 6+ years of

related reading

• Rebuild Biotech for the AI Era | Benchlingbenchling.com
• Tech vs Biotech - Celine Haliouacelinehh.com
• Liquidity in Drug Discovery – Bharath Ramsundar – Entrepreneur and Scientistrbharath.github.io
• AI Versus Eroom's Lawsubstack.com
• Where are all the trillion dollar biotechs?ladanuzhna.xyz
• Why is progress in biology so slow?sam-rodriques.com
• Curious cases of financial engineering in biotechowlposting.com
• What will it take for AI to change drug discovery?writingruxandrabio.com
• On AI Infrastructure in Biology - by Elliot Hershbergcenturyofbio.com
• Convictionconviction.com
• Intelligence is not the main bottleneck - by Ruxandra Teslowritingruxandrabio.com
• Anatomy of a Biotech Business Development Deal | Andreessen Horowitza16z.com